Clinical Trial Update: A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Hibero SR (mirabegron) 50 mg and Ditropan (oxybutynin chloride) 10 mg for efficacy and safety in children aged 5-18 with overactive bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Ditropan (oxybutynin)
• Hibero SR (mirabegron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Overactive Bladder | Phase 2 | Status: UNKNOWN